Biotech

All Articles

' All palms on deck' at Lilly as peers target obesity market

.CEO David Ricks can easily view the providers establishing outdoors tents at basecamp responsible f...

Entero giving up team, moving out of workplace and also stopping briefly R&ampD

.Bed mattress Liquidators has transformed Entero Rehabs white as a piece. The lender got Entero to r...

Exelixis falls ADC after determining it is actually no match for Tivdak

.Exelixis is actually losing hope on its tissue factor (TF)- targeting antibody-drug conjugate after...

Relay loses interest in SHP2 prevention after Genentech leaves

.Three full weeks after Roche's Genentech unit walked away from an SHP2 prevention pact, Relay Thera...

Stoke's Dravet disorder med released of partial clinical grip

.Stoke Therapies' Dravet syndrome drug has actually been actually freed from a predisposed grip, cle...

Fierce Biotech's Gabrielle Masson shows Brutal 15 at NYSE

.Ferocious Biotech Partner Editor Gabrielle Masson offered the 2024 course of Ferocious 15 winners o...

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH prospect

.Novo Nordisk has actually axed its own once-monthly dual GLP-1/ GIP receptor agonist, ending (PDF) ...

Daiichi pays Merck $170M to form bronchi cancer cells T-cell engager treaty

.Merck &amp Co. has quickly gotten back a number of the costs of its own Javelin Rehabs purchase, at...

BioMarin standstills preclinical genetics treatment for heart condition

.After BioMarin conducted a spring well-maintained of its own pipe in April, the firm has made a dec...

Eisai plants molecular adhesive SEED with $1.5 B biobucks deal

.Major Pharmas continue to be stuck to the tip of molecular adhesive degraders. The latest business ...